title: Trastuzumab-related thrombocytopenia: always a self-limiting complication?
authors.affiliation: Department of Oncology and Oncohematology, Infermi Hospital, Rimini; Cancer Institute of Romagna, Meldola, Italy. Electronic address: f.drudi1@virgilio.it.
authors.forename: F
authors.initials: F
authors.lastname: Drudi
authors.affiliation: Department of Oncology and Oncohematology, Infermi Hospital, Rimini; Cancer Institute of Romagna, Meldola, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Gianni
authors.affiliation: Department of Oncology and Oncohematology, Infermi Hospital, Rimini; Cancer Institute of Romagna, Meldola, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Fantini
authors.affiliation: Department of Oncology and Oncohematology, Infermi Hospital, Rimini; Cancer Institute of Romagna, Meldola, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Ravaioli
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D011379:Prognosis; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab